<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05109923</url>
  </required_header>
  <id_info>
    <org_study_id>18-138</org_study_id>
    <nct_id>NCT05109923</nct_id>
  </id_info>
  <brief_title>Onnit Labs New Mood Supplementation in Healthy College Students</brief_title>
  <official_title>The Effect of Onnit New Mood Supplementation in Healthy Collegiate Men and Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Idaho</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Idaho</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to assess the effectiveness of ONNIT Lab's New Mood™&#xD;
      dietary supplement in supporting optimal mood balance and reducing daily stress among&#xD;
      collegiate-aged men and women. To be considered for this study, the participant must meet the&#xD;
      following criteria: (1) current undergraduate student at the University of Idaho between&#xD;
      18-24 years of age, (2) have no known allergies to the ingredients of New Mood™ (Niacin,&#xD;
      Vitamin B6, Magnesium, Valerian Extract, Lemon Balm Extract, L-Tryptophan.&#xD;
      5-Hydroxytryptophan, and Inositol) or the placebo (rice bran and maltodextrin), (3) not&#xD;
      currently taking any mood/sleep supplementation or medications, (4) not currently seeking&#xD;
      therapy or diagnosed with a psychological disorder, (5) not regularly using cigarettes,&#xD;
      marijuana, or other illicit drugs, and (6) not pregnant or breastfeeding.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 10, 2018</start_date>
  <completion_date type="Actual">August 2, 2019</completion_date>
  <primary_completion_date type="Actual">May 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cortisol awakening response (mg/dL) over 8 weeks</measure>
    <time_frame>Change from baseline cortisol awakening response (mg/dL) at 8 weeks</time_frame>
    <description>Three salivary cortisol measurements to determine cortisol awakening response (mg/dL) from baseline to 8 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in resting heart rate (beats per minute) over 8 weeks</measure>
    <time_frame>Change from baseline resting heart rate (beats per minute) response at 8 weeks</time_frame>
    <description>Manual radial pulse measurement of resting heart rate (beats per minute) at baseline and 8 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in resting systolic and diastolic blood pressure (mm Hg) over 8 weeks</measure>
    <time_frame>Change from baseline resting systolic and diastolic blood pressure (mm Hg) at 8 weeks</time_frame>
    <description>Digital sphygmomanometer measurement of resting systolic and diastolic blood pressure (mm Hg) at baseline and 8 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in depression, anxiety and stress scores (0-34) over 8 weeks</measure>
    <time_frame>Change from baseline DASS-21 score at 8 weeks</time_frame>
    <description>Depression, Anxiety and Stress Scale Questionnaire (DASS-21, 0-34) to assess depression, anxiety and stress scores from baseline to 8 weeks</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Mental Health Wellness 1</condition>
  <arm_group>
    <arm_group_label>New Mood Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The New Mood herbal supplement includes lemon balm, 5-HPT, L-Tryptophan and valerian root.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Supplementation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo includes rice bran and maltodextrin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multi-Ingredient Herbal Supplement</intervention_name>
    <description>Weeks 0-2 all participants consumed a placebo lead-in period and weeks 2-6 were intervention weeks. Throughout the 8 weeks (2 weeks placebo lead-in and 6 weeks intervention) participants were asked to consume 2 capsules (multi-ingredient supplement) upon waking in the morning and 2 capsules (multi-ingredient supplement) before bed.</description>
    <arm_group_label>New Mood Supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo Supplement</intervention_name>
    <description>Weeks 0-8 all participants consumed a placebo. Throughout the 8 weeks participants were asked to consume 2 capsules (placebo) upon waking in the morning and 2 capsules (placebo) before bed.</description>
    <arm_group_label>Placebo Supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Currently enrolled collegiate men and women at the University of Idaho&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently taking mood or sleep enhancing supplementation/medication&#xD;
&#xD;
          -  Currently participating in counseling and/or therapy sessions&#xD;
&#xD;
          -  Previously diagnosed with a psychological disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Idaho</name>
      <address>
        <city>Moscow</city>
        <state>Idaho</state>
        <zip>83844</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 10, 2020</study_first_submitted>
  <study_first_submitted_qc>October 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2021</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Idaho</investigator_affiliation>
    <investigator_full_name>Ann Brown</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>cortisol</keyword>
  <keyword>mood</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

